Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2018-10-16 2018-09-14
Drug Identification Number 02236926 02236926
Brand name ACYCLOVIR SODIUM INJECTION ACYCLOVIR SODIUM INJECTION
Common or Proper name Acyclovir Sodium Injection Acyclovir Sodium Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients ACYCLOVIR ACYCLOVIR
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20mL 20mL
ATC code J05AB J05AB
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-09-17 2018-09-17
Actual start date
Estimated end date 2018-10-12
Actual end date 2018-10-15
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Our Acyclovir Sodium Injection 50 mg/mL 10 mL Vial is available for substitution:
Health Canada comments